MedPath

GRANISETRON HYDROCHLORIDE

These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. Granisetron Hydrochloride Injection, USP, for intravenous use Initial U.S. Approval: 1993

Approved
Approval ID

af68579f-c863-4535-94af-a4126b43c182

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2011

Manufacturers
FDA

WOCKHARDT LIMITED

DUNS: 650069115

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

GRANISETRON HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55648-661
Application NumberANDA078565
Product Classification
M
Marketing Category
C73584
G
Generic Name
GRANISETRON HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 29, 2011
FDA Product Classification

INGREDIENTS (8)

GRANISETRON HYDROCHLORIDEActive
Quantity: 1 mg in 1 mL
Code: 318F6L70J8
Classification: ACTIM
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GRANISETRON HYDROCHLORIDE - FDA Drug Approval Details